With a median age of approximately 70 years, multiple myeloma is a disease of the elderly. However, there are age-related differences in the frequency of early cytogenetic events, bone marrow microenvironment and immune system, as Niels van de Donk, MD, PhD (VU Medical Centre, Amsterdam) pointed out at the 2015 annual EHA meeting in Vienna.

(BELG J HEMATOL 2015;6(3):113